Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models - Concepedia

Concepedia

Publication | Closed Access

Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models

22

Citations

32

References

2007

Year

Anna M. Grabowska, Teresa Morris, Andrew J. McKenzie, Rajendra Kumari, Hiroki Hamano, Yutaka Emori, Koji Yoshinaga, S A Watson

Regulatory Peptides

OncologyChemoprevention StrategyGastrointestinal OncologyPre-clinical EvaluationMedicineGastroenterologyPathologyGastrointestinal Cancer ModelsPharmacotherapyCancer TreatmentPharmacologyCancer Research

References

	Year	Citations

Page 1

Page 1